You have accessJournal of UrologyCME1 Mar 2024The Journal of Urology® Home Study Course 2024 Volume 211/212 View All Author Informationhttps://doi.org/10.1097/JU.0000000000003843AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail AUA CME Requirements Program Description and Objectives:The Journal of Urology® Home Study Course is a comprehensive learning activity developed by a team of educators, academicians and clinicians. After completing each lesson, the participants will be able to assess their knowledge of urology, demonstrate an increased knowledge base of urology, and apply the increased knowledge to improve quality of patient care. Target Audience:The Journal of Urology® Home Study Course is designed for practicing urologic physicians, American Board of Urology (ABU) candidates and/or residents. Estimated time to complete each lesson: 2.0 hours. Program Enrollment: Enroll by visiting AUAnet.org/JUHS. Method of participation in the learning process: Two volumes of The Journal of Urology® are published annually. Each volume is comprised of 6 issues. Five clinically relevant articles are selected by the editor to be offered for CME in each issue of The Journal. For CME credit, the participant must be enrolled in the home study course for the year, read the educational material provided, pass the corresponding online posttest with 80% accuracy, submit the online evaluation and claim CME. Please go to: AUAnet.org/JU24. Each issue is designated for a maximum of 2.0 AMA PRA Category 1 Credits™. Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation: The American Urological Association designates this enduring material for a maximum of 24.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™. Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME enduring material activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias. AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest (aka ineligible company) during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments. Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest: • Peer review for valid, evidence-based content by the AUA COI Review Work Group • Attestation that clinical recommendations are evidence-based and free of commercial bias • Introduction of a debate format with an unbiased moderator (point-counterpoint) • Inclusion of moderated panel with unbiased moderator • Publication of a parallel or rebuttal article for an article that is felt to be biased • Divestiture of the relationship by faculty • Recusal from controlling relevant aspects of planning • Selection of alternative faculty for specific topic Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to offlabel or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses. Disclosures: A complete list of disclosures can be found at AUAnet.org/JU24Disclosures. All relevant financial disclosures from the JU Editorial Board and authors have been mitigated. Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA. Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association. Release Date: Issue month, 2024. Expiration Date: Issue month, 2027. Copyright © 2024 by american urological association education and research, inc. Email education@AUAnet.orgwith any questions. CME Questions for the March 2024 Issue of The Journal of Urology® 1. Prospective Multicenter Evaluation of Pain Before and After Removal of Nonobstructing Renal Calculi: A CoRE Initiative (vol. 211, pp. 436-444) The removal of nonobstructing calyceal kidney stones can result in: a) a significant reduction in pain b) a significant improvement in quality of life c) both (a) and (b) d) no significant change in the patient’s condition 2. Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy? (vol. 211, pp. 400-406) With regard to biochemical recurrence (BCR) in men using phosphodiesterase type 5 inhibitors regularly after radical prostatectomy: a) there is a decrease in the time to BCR development b) there is an increase in BCR rates c) there is an increase in the time to BCR development d) there is no increase in BCR rates 3. Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical Prostatectomy (vol. 211, pp. 407-414) A 65-year-old male undergoes a radical prostatectomy with final pathology showing Grade Group (GG) 1 prostate cancer (PCa) with focal extracapsular extension (ECE). His risk of biochemical recurrence is: a) higher than a patient with GG1 PCa without ECE b) similar to a patient with GG1 PCa without ECE c) lower than a patient with GG1 PCa without ECE d) similar to a patient with GG2 PCa 4. Affirming Long-Term Outcomes After Contemporary Urethroplasty: The Adverse Impact of Increasing Stricture Length, Lichen Sclerosus, Radiation, and Infectious Strictures (vol. 211, pp. 455-464) When counselling a patient regarding treatment options for recurrent urethral stricture, which clinical factor is most strongly associated with long-term stricture recurrence after urethroplasty? a) number of failed prior endoscopic treatments b) lichen sclerosus c) patient age d) tobacco use 5. A Randomized Controlled Trial of a Web-Based Management Support System for Children With Urinary Incontinence: The eADVICE Trial (vol. 211, pp. 364-375) Comparing eADVICE (electronic Advice and Diagnosis Via the Internet following Computerized Evaluation) to standard therapy for children with treatment-resistant enuresis awaiting their continence clinic appointment, which treatment is more likely to be received by those using eADVICE? a) enuresis alarm training b) urotherapy c) desmopressin d) anticholinergics Publication date: March 2024 Expiration date: March 2027 Answers to questions and CME credit can be obtained at AUAnet.org/JU24. © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 3March 2024Page: 504-505 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Expand All Answers to questions and CME credit can be obtained at AUAnet.org/JU24. Advertisement Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: